Novel vaccines: Technology and development
- PMID: 29970235
- PMCID: PMC6311446
- DOI: 10.1016/j.jaci.2018.05.021
Novel vaccines: Technology and development
Abstract
The development and widespread use of vaccines, which are defined by the World Health Organization as "biological preparations that improve immunity to a particular disease," represents one of the most significant strides in medicine. Vaccination was first applied to reduce mortality and morbidity from infectious diseases. The World Health Organization estimates that vaccines prevent 2 to 3 million human deaths annually, and these numbers would increase by at least 6 million if all children received the recommended vaccination schedule. However, the origins of allergen immunotherapy share the same intellectual paradigm, and subsequent innovations in vaccine technology have been applied beyond the prevention of infection, including in the treatment of cancer and allergic diseases. This review will focus on how new and more rational approaches to vaccine development use novel biotechnology, target new mechanisms, and shape the immune system response, with an emphasis on discoveries that have direct translational relevance to the treatment of allergic diseases.
Keywords: Vaccines; antibodies; immunotherapy; sequencing.
Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Conflict of Interest
This work did not receive any specific grant from funding agencies in the public, commercial, or not for profit sectors.
Figures

References
-
- Jenner E An inquiry into the causes and effects of the variolae vaccinae, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of the cow pox. London,: Law; 1798.
-
- Noon L PROPHYLACTIC INOCULATION AGAINST HAY FEVER. The Lancet 1911; 177:1572–3.
-
- Freeman J FURTHER OBSERVATIONS ON THE TREATMENT OF HAY FEVER BY HYPODERMIC INOCULATIONS OF POLLEN VACCINE. The Lancet 1911; 178:814–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical